Life Science Leader Magazine Supplements

CMO Leadership Awards 2012

The vision of Life Science Leader is to be an essential business tool for life science executives. Our content is designed to not only inform readers of best practices, but motivate them to implement those best practices in their own businesses.

Issue link: https://lifescienceleadermag.epubxp.com/i/85321

Contents of this Issue

Navigation

Page 47 of 59

Uman Pharma Inc. Candiac, Québec, Canada www.umanpharma.com (450) 444-9989 DRUG TYPE: Pharmaceuticals DRUG LIFE CYCLE STAGES: Research & Development – pre-clinical and clinical (phase 1, phase 2, and phase 3) Drug Substance Production – primary process development and drug substance production Formulated Drug Production – dosage form development, dosage form production, packaging, and logistics SERVICES OFFERED: Capsules, cytotoxic & high-potency compounds, generics, injectables, liquids, lyophilized products, non-sterile, OTC, solid dose, solutions & suspensions, sterile, and syringes (pre-filled). "We are very happy to have been bestowed this honor by Life Science Leader, especially since this CMO Leadership Award comes from within the industry. As a young company, we are extremely proud of our accomplishments to date, and our mission has always been to provide excellence in both products and services. We recognize and are fortunate to have an experienced, professional and dedicated team that is committed to the highest pharmaceutical quality standards. To have and to bring a Uman touch is our motto and it drives us to attain new heights." — Sylvain Duvernay, CEO Manufacturing location: Candiac, Québec, Canada Contact: Alain Huneault alain.huneault@umanpharma.com DRUG LIFE CYCLE STAGES: Research & Development – clinical (phase 1, phase 2, and phase 3) Formulated Drug Production – dosage form development, dosage form production, and packaging SERVICES OFFERED: Capsules, controlled substances, cytotoxic & high-potency compounds, gels, generics, liquids, non-sterile, peptides, powders (non-sterile), semisolids, soft gels, solutions & suspensions, and topicals. "UPM Pharmaceuticals focuses on meeting challenging timelines for devel- opment work, provision of clinical supplies, and associated lab services. UPM maintains a lean and flat corporate structure. This allows production decisions and quality oversight on every project to be made and driven daily with input from every department and overseen at the highest levels of our operations. We pride ourselves on providing constant communication with our clients. UPM clearly understands that winning and keeping business in this highly competitive industry is about producing results for our clients." — Jim Gregory, president and COO Vetter Pharma International GmbH Ravensburg, Germany www.vetter-pharma.com +49-751-3700-0 DRUG TYPE: Pharmaceuticals and Biopharmaceuticals Manufacturing locations: Langenargen, Germany, Ravensburg, Germany, and Skokie, IL Contact: Oskar Gold info@vetter-pharma.com DRUG LIFE CYCLE STAGES: Research & Development – pre-clinical and clinical (phase 1, phase 2, and phase 3) Formulated Drug Production – dosage form production, packaging, and logistics SERVICES OFFERED: Aseptic fill/finish, cartridges, injectables, liquids, lyophilized products, parenterals (large volume), parenterals (small volume), peptides, powders (sterile), proteins, solutions & suspensions, sterile, syringes (pre-filled), and vaccines. "We never lose sight that the products we manufacture for our clients are used by patients they serve. For more than 25 years, Vetter has provided high-quality aseptic fill and finish with reliable delivery. We appreciate recognition of our dedication to our customers with this award." — Peter Soelkner, Vetter Managing Director DRUG TYPE: Pharmaceuticals and Biopharmaceuticals WuXi AppTec Shanghai, People's Republic of China www.WuXiAppTec.com 86 (21) 5046-1111 Manufacturing locations: Changzhou, Jinshan, WuXi City, and Shanghai WGQ, China Contact: Yu Lu Yu.Lu@WuXiAppTec.com DRUG LIFE CYCLE STAGES: Research & Development – discovery, pre-clinical, & clinical (phase 1, phase 2, & phase 3) Drug Substance Production – primary process development and drug substance production Formulated Drug Production – dosage form development, dosage form production, packaging, and logistics SERVICES OFFERED: Capsules, liquids, non-sterile, peptides, powders (non-sterile), solid dose, solutions & suspensions, sustained release, and vaccines. DRUG TYPE: Pharmaceuticals UPM Pharmaceuticals, Inc. Baltimore, MD www.upm-inc.com (410) 843-3700 Manufacturing location: Baltimore, MD Contact: Mike Raum raum@upm-inc.com "We are honored to be consistently recognized as a top outsourcing company in China. This speaks volume for WuXi's service business model. As a leading life science R&D; service company, we will strive to improve our capabilities and capacities to better serve our pharmaceutical, biotechnology, and medical device customers and partners, to help bring new products into market sooner and more cost effectively to benefit patients needs." — Suhan Tang, Ph.D., chief manufacturing officer 48 The CMO Leadership Awards 2012 DRUG LIFE CYCLE STAGES

Articles in this issue

Links on this page

Archives of this issue

view archives of Life Science Leader Magazine Supplements - CMO Leadership Awards 2012